RT Journal Article
SR Electronic
T1 The health sector cost of different policy responses to COVID-19 in low- and middle-income countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.23.20180299
DO 10.1101/2020.08.23.20180299
A1 Torres-Rueda, Sergio
A1 Sweeney, Sedona
A1 Bozzani, Fiammetta
A1 Vassall, Anna
YR 2020
UL http://medrxiv.org/content/early/2020/08/25/2020.08.23.20180299.abstract
AB Much attention has focussed in recent months on the impact that COVID-19 has on health sector capacity, including critical care bed capacity and resources such as personal protective equipment. However, much less attention has focussed on the overall cost to health sectors, including the full human resource costs and the health system costs to address the pandemic. Here we present estimates of the total costs of COVID-19 response in low- and middle-income countries for different scenarios of COVID-19 mitigation over a one year period. We find costs vary substantially by setting, but in some settings even mitigation scenarios place a substantial fiscal impact on the health system. We conclude that the choices facing many low- and middle-income countries, without further rapid emergency financial support, are stark, between fully funding an effective COVID-19 reponse or other core essential health services.This is preliminary report that has not yet been peer reviewed. These estimates should not yet guide policy in specific countries nor be reported as established information. We are placing these in the public domain to inform those who are estimaing Covid costs in low- and middle-income countries about the methods and assumptions required; higlight the broad level of fiscal impact and to invite comments for others working in this field, prior to submission to peer review publication.These estimates have been subjected to a detailed validation and error checking process internally. Nevertheless, given the dearth of data to inform Covid cost estimates at this time, our results depend on a range of assumptions. Comments and suggestions to improve this work are welcomed and can be sent to the authors belowCompeting Interest StatementThe authors have declared no competing interest.Funding StatementWellcome Trust. Department of International Development, United KingdomAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:London School of Hygiene and Tropical Medicine All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have included the data in the main text of the report, which contains supplementary material